XML 13 R2.htm IDEA: XBRL DOCUMENT v3.8.0.1
Consolidated Balance Sheets (Current Period Unaudited) - USD ($)
$ in Thousands
Apr. 01, 2018
Dec. 31, 2017
Current assets:    
Cash $ 18,239 $ 18,241
Restricted Cash 91 89
Trade Accounts Receivable, Net of Allowance for Doubtful Accounts of $298 and $292, Respectively 15,730 14,657
Inventories, Net 26,961 26,326
Prepaid Expenses and Other Current Assets 2,730 2,603
Total Current Assets 63,751 61,916
Property, Equipment and Improvements, Net 7,359 7,570
Goodwill 20,698 20,458
Other Intangible Assets, Net 7,119 7,085
Deferred Income Taxes 32 32
Security Deposits and Other Non-Current Assets 118 125
Total Assets 99,077 97,186
Current Liabilities:    
Accounts Payable 7,545 8,787
Accrued Compensation and Related Benefits 1,694 2,413
Accrued Expenses and Other Current Liabilities 2,595 2,871
Income Taxes Payable 245 168
Total Current Liabilities 12,079 14,239
Deferred Income Taxes 3,874 3,867
Other Non-Current Liabilities 31 31
Total Liabilities 15,984 18,137
Commitments and Contingencies (Note 11)
Shareholders' Equity:    
Preferred Stock – Par Value $.10 Per Share; Authorized 1,000,000 Shares; None Issued
Common Stock – Par Value $.10 Per Share; Authorized 40,000,000 Shares; Issued – 19,891,937 Shares at April 1, 2018 and 19,670,928 Shares at December 31, 2017; Outstanding – 15,872,226 Shares at April 1, 2018 and 15,651,217 at December 31, 2017 1,989 1,966
Capital in Excess of Par Value 181,312 180,211
Accumulated Deficit (80,743) (82,894)
Accumulated Other Comprehensive Loss (859) (1,611)
Treasury Stock - At Cost; 4,019,711 at April 1, 2018 and 4,019,711 Shares at December 31, 2017 (18,469) (18,469)
Total Ultralife Corporation Equity 83,230 79,203
Non-Controlling Interest (137) (154)
Total Shareholders’ Equity 83,093 79,049
Total Liabilities and Shareholders' Equity $ 99,077 $ 97,186